zintick

Anavex Life Sciences AVXL

Anavex Life Sciences Corp. · Nasdaq · Biological Products, (No Diagnostic Substances)

$1.30-0.76%close on Oct. 28, 2026 · volume 1.0M · Yahoo Finance

Price, last 47 sessions

$2.00$3.00Sept. 2026Oct. 2026
Aug. 24, 2026 to Oct. 28, 2026 · high $3.56 · low $1.25 · SEC filing, placed when SEC released it

Our coverage

Nothing published yet.

Insider buying and selling

No open-market insider buying or selling in the Form 4s filed since July 24, 2026.

Recent SEC filings

All 16 →
  • 8-KOct. 20, 2026, 4:16 p.m. ETView on SEC.gov

    Other events · Financial statements and exhibits

    AI summary, unreviewedAnavex Life Sciences Corp. Completes Clinical Conduct of Blarcamesine ADME and DDI Pharmacology Studies; No Financial Figures Disclosed

  • 8-KOct. 15, 2026, 4:18 p.m. ETView on SEC.gov

    Other events · Financial statements and exhibits

  • 4Sept. 28, 2026, 9:36 p.m. ETView on SEC.gov
  • 8-KSept. 28, 2026, 5:27 p.m. ETView on SEC.gov

    Change in control · Submission of matters to a vote of security holders

  • 8-KSept. 9, 2026, 5:17 p.m. ETView on SEC.gov

    Other events

  • 8-KSept. 2, 2026, 5:06 p.m. ETView on SEC.gov

    Other events · Financial statements and exhibits

  • 10-QAug. 28, 2026, 4:28 p.m. ETView on SEC.gov
  • 10-QAug. 28, 2026, 4:26 p.m. ETView on SEC.gov